Menu

TEVA Pharmaceutical Industries Ltd (TEVA)Add to comparisonRemove from comparison

Latest financial period: September 30, 2026
Filed with the SEC: November 3, 2026
Estimated earnings date: Not available

Profit #987 of 1422 companies

 Sep 26Jun 26Mar 26Dec 25
ROE/ROA29.8%27.4%32.4%29.2%

Growth #727 of 1422 companies

 Sep 26Jun 26Mar 26Dec 25
Sales andOCF growth21.5%14.8%14.7%13.7%

Payout #1089 of 1422 companies

 Sep 26Jun 26Mar 26Dec 25
Shareholderdistributions/ net income0%0%0%0%

Safety #1203 of 1422 companies

 BalanceStability
Equity/assets andOCF stability19.3%58.6%

Price #1257 of 1422 companies

 EarningsFCF
Earnings andFCF yield$0.31$0.76